Table of Contents
International Journal of Molecular Imaging
Volume 2011, Article ID 405840, 9 pages
http://dx.doi.org/10.1155/2011/405840
Research Article

Comparison of the In Vivo Distribution of Four Different Annexin A5 Adducts in Rhesus Monkeys

1Imaging Research, Merck Research Laboratories, West Point, PA 19486, USA
2Department of Biochemistry, University Maastricht, 6200 NL Maastricht, The Netherlands
3Diabetes Exploratory Biomarker, Merck Research Laboratories, West Point, PA 19486, USA

Received 5 October 2010; Revised 19 January 2011; Accepted 23 February 2011

Academic Editor: Habib Zaidi

Copyright © 2011 Paul McQuade et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. H. Boersma, B. L. J. H. Kietselaer, L. M. L. Stolk et al., “Past, present, and future of annexin A5: from protein discovery to clinical applications,” Journal of Nuclear Medicine, vol. 46, no. 12, pp. 2035–2050, 2005. View at Google Scholar · View at Scopus
  2. S. J. Martin, C. P. M. Reutelingsperger, A. J. McGahon et al., “Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl,” Journal of Experimental Medicine, vol. 182, no. 5, pp. 1545–1556, 1995. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Wong, V. Kumar, R. B. Howman-Giles, and J. L. Vanderheyden, “Imaging of therapy-induced apoptosis using 99mTc-HYNIC-Annexin V in thymoma tumor-bearing mice,” Cancer Biotherapy and Radiopharmaceuticals, vol. 23, no. 6, pp. 715–725, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. K. J. Yagle, J. F. Eary, J. F. Tait et al., “Evaluation of F-annexin V as a PET imaging agent in an animal model of apoptosis,” Journal of Nuclear Medicine, vol. 46, no. 4, pp. 658–666, 2005. View at Google Scholar · View at Scopus
  5. B. Dekker, H. Keen, D. Shaw et al., “Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124,” Nuclear Medicine and Biology, vol. 32, no. 4, pp. 403–413, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. H. Fonge, M. de Saint Hubert, K. Vunckx et al., “Preliminary in vivo evaluation of a novel 99mTc-Labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 13, pp. 3794–3798, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. S. Rottey, G. Slegers, S. Van Belle, I. Goethals, and C. Van De Wiele, “Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy,” Journal of Nuclear Medicine, vol. 47, no. 11, pp. 1813–1818, 2006. View at Google Scholar · View at Scopus
  8. R. L. M. Haas, D. De Jong, R. A. Valdés Olmos et al., “In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients,” International Journal of Radiation Oncology Biology Physics, vol. 59, no. 3, pp. 782–787, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. H. Kurihara, D. J. Yang, M. Cristofanilli et al., “Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors,” Applied Radiation and Isotopes, vol. 66, no. 9, pp. 1175–1182, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. F. Corsten, L. Hofstra, J. Narula, and C. P. M. Reutelingsperger, “Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance,” Cancer Research, vol. 66, no. 3, pp. 1255–1260, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. M. De Saint-Hubert, K. Prinsen, L. Mortelmans, A. Verbruggen, and F. M. Mottaghy, “Molecular imaging of cell death,” Methods, vol. 48, no. 2, pp. 178–187, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. D. L. Kukis, G. L. DeNardo, S. J. DeNardo et al., “Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates,” Cancer Research, vol. 55, no. 4, pp. 878–884, 1995. View at Google Scholar · View at Scopus
  13. F. Al-Ejeh, J. M. Darby, B. Thierry, and M. P. Brown, “A simplified suite of methods to evaluate chelator conjugation of antibodies: effects on hydrodynamic radius and biodistribution,” Nuclear Medicine and Biology, vol. 36, no. 4, pp. 395–402, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. K. Knogler, J. Grünberg, I. Novak-Hofer, K. Zimmermann, and P. A. Schubiger, “Evaluation of Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo properties,” Nuclear Medicine and Biology, vol. 33, no. 7, pp. 883–889, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. R. Huber, R. Berendes, A. Burger et al., “Crystal and molecular structure of human annexin V after refinement: implications for structure, membrane binding and ion channel formation of the annexin family of proteins,” Journal of Molecular Biology, vol. 223, no. 3, pp. 683–704, 1992. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Greupink, C. F. Sio, A. Ederveen, and J. Orsel, “Evaluation of a 99mTc-labeled annexina5 variant for non-invasive spect imaging of cell death in liver, spleen and prostate,” Pharmaceutical Research, vol. 26, no. 12, pp. 2647–2656, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. W. Cai, Y. Wu, K. Chen, Q. Cao, D. A. Tice, and X. Chen, “In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin αβ,” Cancer Research, vol. 66, no. 19, pp. 9673–9681, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. K. W. Ward and B. R. Smith, “A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance,” Drug Metabolism and Disposition, vol. 32, no. 6, pp. 603–611, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. K. W. Ward and B. R. Smith, “A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time,” Drug Metabolism and Disposition, vol. 32, no. 6, pp. 612–619, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. R. Nagilla and K. W. Ward, “A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans,” Journal of Pharmaceutical Sciences, vol. 93, no. 10, pp. 2522–2534, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. J. F. Tait, D. F. Gibson, and C. Smith, “Measurement of the affinity and cooperativity of annexin V-membrane binding under conditions of low membrane occupancy,” Analytical Biochemistry, vol. 329, no. 1, pp. 112–119, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. A. Swairjo and B. A. Seaton, “Annexin structure and membrane interactions: a molecular perspective,” Annual Review of Biophysics and Biomolecular Structure, vol. 23, pp. 193–213, 1994. View at Google Scholar · View at Scopus
  23. F. E. Boas, L. Forman, and E. Beutler, “Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 6, pp. 3077–3081, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Huhalov and K. A. Chester, “Engineered single chain antibody fragments for radioimmunotherapy,” Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 4, pp. 279–288, 2004. View at Google Scholar · View at Scopus
  25. G. J. Kemerink, I. H. Liem, L. Hofstra et al., “Patient dosimetry of intravenously administered 99mTc-annexin V,” Journal of Nuclear Medicine, vol. 42, no. 2, pp. 382–387, 2001. View at Google Scholar · View at Scopus
  26. G. J. Kemerink, H. H. Boersma, P. W. Thimister et al., “Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans,” European Journal of Nuclear Medicine, vol. 28, no. 9, pp. 1373–1378, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Kurihara, D. J. Yang, M. Cristofanilli et al., “Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors,” Applied Radiation and Isotopes, vol. 66, no. 9, pp. 1175–1182, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. J. F. Tait, C. Smith, and F. G. Blankenberg, “Structural requirements for in vivo detection of cell death with 99mTc-annexin V,” Journal of Nuclear Medicine, vol. 46, no. 5, pp. 807–815, 2005. View at Google Scholar · View at Scopus
  29. J. L. Vanderheyden, G. Liu, J. He, B. Patel, J. F. Tait, and D. J. Hnatowich, “Evaluation of 99mTc-MAG-annexin V: influence of the chelate on in vitro and in vivo properties in mice,” Nuclear Medicine and Biology, vol. 33, no. 1, pp. 135–144, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. H. H. Boersma, I. H. Liem, G. J. Kemerink et al., “Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-Annexin A5,” British Journal of Radiology, vol. 76, no. 908, pp. 553–560, 2003. View at Publisher · View at Google Scholar · View at Scopus